Screening compound: C21H22N6O5S (M334-0076)

Screening compound: C<sub>21</sub>H<sub>22</sub>N<sub>6</sub>O<sub>5</sub>S (M334-0076)
Screening compound: C<sub>21</sub>H<sub>22</sub>N<sub>6</sub>O<sub>5</sub>S (M334-0076) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C21H22N6O5S (M334-0076)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M334-0076

Molecular Formula

C21H22N6O5S (C21 H22 N6 O5 S)

Compound Name

2-[6-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-3-(propan-2-yl)-2,3-dihydro-1H-1,3-benzodiazol-1-yl]-N-(4-sulfamoylphenyl)acetamide

IUPAC name

2-[6-(5-methyl-124-oxadiazol-3-yl)-2-oxo-3-(propan-2-yl)-23-dihydro-1H-13-benzodiazol-1-yl]-N-(4-sulfamoylphenyl)acetamide

SMILES

CC(C)N(c(ccc(-c1noc(C)n1)c1)c1N1CC(Nc(cc2)ccc2S(N)(=O)=O)=O)C1=O

InChI

InChI=1S/C21H22N6O5S/c1-12(2)27-17-9-4-14(20-23-13(3)32-25-20)10-18(17)26(21(27)29)11-19(28)24-15-5-7-16(8-6-15)33(22,30)31/h4-10,12H,11H2,1-3H3,(H,24,28)(H2,22,30,31)

InChI Key

UMFOMTXGGLELRO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27536896

C21H22N6O5S (M334-0076) in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Hsp90-Targeted Library (11355 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Carbonic Anhydrase II Library (4939 compounds)

Peptidomimetic Library (37031 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
  • Epigenetic
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Targets:
  • Others
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with C21H22N6O5S (M334-0076) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C21H22N6O5S (M334-0076)?
Check Price and Availability of C21H22N6O5S (M334-0076), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C21H22N6O5S (M334-0076) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C21H22N6O5S (M334-0076)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C21H22N6O5S (M334-0076)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C21H22N6O5S (M334-0076) available by request